Updated Oct 28, 2026 · 12:56 UTC
RVMDRevolution Medicines, Inc.
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$185.19+1.26%last session · market early-hours
Market cap
$39.69b
real-world
Tokenized
$2k
<0.001% of the asset
Avg token price
$189.60
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
RVMD · Price
EarningsNasdaq’s earnings calendar
Next earnings
Nov 4
after the close · Sep 2026 quarter · EPS forecast −$2.34 (11 analysts)
Last earnings, Aug 5
−$2.34 EPS
−21.2% vs −$1.93 forecast · Jun 2026 quarter
Real marketRevolution Medicines, Inc. Common Stock
Last close
$186.22
Oct 27
Traded on Oct 27
$217.6m
Price now
$185.19
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions1 token from 1 issuer
wRVMDxBacked Assets——